ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA approves AstraZeneca-Amgen’s Tezspire for severe asthma treatment Pharmaceutical-Technology
December 21, 2021The US Food and Drug Administration (FDA) has granted approval to AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) as an add-on maintenance therapy for severe asthma in adults and paediatric individuals of the age 12 years and above.
Pharma Sources Insight July 2025
